opentargets-database

You can retrieve target-disease evidence by querying the Open Targets GraphQL endpoint with specific entity IDs like Ensembl for targets and EFO for diseases, selecting desired evidence fields with pagination-safe querying.

Drug repurposing workflows can gather evidence associations across genetic, somatic, pathway, expression, animal-model, and literature sources, alongside tractability, safety liabilities, and known-drug mechanisms.

Yes, you can query Open Targets using ChEMBL IDs for drugs alongside Ensembl IDs for targets and EFO IDs for diseases to map candidates to indications and review known drug phases.

Genetic constraint data supports target prioritization by allowing you to review tractability and safety liabilities alongside multi-source evidence workflows, enabling faster therapeutic hypothesis building.

Yes, querying Open Targets requires constructing GraphQL requests to the endpoint with correct entity IDs and selecting evidence fields with pagination-safe querying to retrieve associations.

Limitations include the strict requirement for correct entity IDs across formats like Ensembl, EFO, and ChEMBL, and the need for pagination-safe querying to handle large evidence datasets.